한국보건사회연구원 한국보건사회연구원

Research in Brief

Characteristics of New Drugs Approved in Korea in 2007~2018

  • 정리ㆍ편집

    Sylvia Park Sol-Leep Ha

  • 65

  • 발행년월

    2020-06

  • 면수

    1-8

As medicinal technologies continue to advance, the development of new drugs, especially those targeting serious conditions like cancer and rare diseases, has been on the global rise. These highpriced specialty drugs account for an increasing share of pharmaceutical expenditure. Also, facilitating the availability of new drugs has become a subject of growing attention, and new methods of ensuring prompt availability of new drugs, such as accelerated approval and risk-sharing arrangements (RSAs),
have been used widely around the world. With the reliance on fast-track approvals growing, however, the evidence on which to base reimbursement decisions is becoming increasingly uncertain.

첨부파일

공공누리 공공저작물 자유 이용허락